1. Home
  2. CDE vs ENOV Comparison

CDE vs ENOV Comparison

Compare CDE & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coeur Mining Inc.

CDE

Coeur Mining Inc.

HOLD

Current Price

$25.49

Market Cap

12.0B

ML Signal

HOLD

Logo Enovis Corporation

ENOV

Enovis Corporation

HOLD

Current Price

$22.74

Market Cap

1.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDE
ENOV
Founded
1928
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Fluid Controls
Sector
Basic Materials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
12.0B
1.6B
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
CDE
ENOV
Price
$25.49
$22.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
8
Target Price
$20.00
$48.13
AVG Volume (30 Days)
22.9M
989.0K
Earning Date
02-18-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.74
N/A
Revenue
$1,700,723,000.00
$2,233,266,000.00
Revenue This Year
$95.35
$9.22
Revenue Next Year
$35.11
$4.60
P/E Ratio
$35.38
N/A
Revenue Growth
68.28
11.57
52 Week Low
$4.58
$22.50
52 Week High
$26.50
$49.38

Technical Indicators

Market Signals
Indicator
CDE
ENOV
Relative Strength Index (RSI) 76.11 32.72
Support Level $20.17 $22.50
Resistance Level $23.74 $24.46
Average True Range (ATR) 1.41 1.28
MACD 0.52 -0.32
Stochastic Oscillator 77.04 3.59

Price Performance

Historical Comparison
CDE
ENOV

About CDE Coeur Mining Inc.

Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada, and Mexico.

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

Share on Social Networks: